Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
06 2020
Historique:
received: 07 10 2019
revised: 22 04 2020
accepted: 27 04 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 7 4 2021
Statut: ppublish

Résumé

Few studies have systematically described population-level differences comparing men and women across the continuum of routine HIV care. This study quantifies differentials in HIV care, treatment and mortality outcomes for men and women over time in South Africa. We analysed population-wide linked anonymized data, including vital registration linkage, for the Western Cape Province, from the time of first CD4 count. Three antiretroviral therapy guideline eligibility periods were defined: 1 January 2008 to 31 July 2011 (CD4 cell count <200 cells/µL), 1 August 2011 to 31 December 2014 (<350 cells/µL), 1 January 2015 to 31 August 2016 (<500 cells/µL). We estimated care uptake based on service attendance, and modelled associations for men and women with ART initiation and overall, pre-ART and ART mortality. Separate Cox proportional hazard models were built for each outcome and eligibility period, adjusted for tuberculosis, pregnancy, CD4 count and age. Adult men made up 49% of the population and constituted 37% of those living with HIV. In 2009, 46% of men living with HIV attended health services, rising to 67% by 2015 compared to 54% and 77% of women respectively. Men contributed <35% of all CD4 cell counts over 10 years and presented with more advanced disease (39% of all first presentation CD4 cell counts from men were <200 cells/µL compared to 25% in women). ART access was lower in men compared to women (AHR 0.79 (0.77 to 0.80) summarized for Period 2) over the entire study). Mortality was greater in men irrespective of ART (AHR 1.08 (1.01 to 1.16) Period 3) and after ART start (AHR 1.15 (1.05 to 1.20) Period 3) with mortality differences decreasing over time. Compared to women, men presented with more advanced disease, were less likely to attend health care services annually, were less likely to initiate ART and had higher mortality overall and while receiving ART care. People living with HIV were more likely to initiate ART if they had acute reasons to access healthcare beyond HIV, such as being pregnant or being co-infected with tuberculosis. Our findings point to missed opportunities for improving access to and outcomes from interventions for men along the entire HIV cascade.

Identifiants

pubmed: 32589367
doi: 10.1002/jia2.25530
pmc: PMC7319137
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25530

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH106600
Pays : United States
Organisme : NIAID NIH HHS
ID : U01AI069924
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH106600
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : 1164272
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States

Informations de copyright

© 2020 World Health Organization; licensed by IAS.

Références

S Afr Med J. 2009 Sep;99(9):653-60
pubmed: 20073292
AIDS. 2015 Jun 19;29(10):1123-5
pubmed: 26035315
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S118-S125
pubmed: 29514233
Lancet Glob Health. 2020 Feb;8(2):e276-e287
pubmed: 31981557
Bull World Health Organ. 2008 Sep;86(9):678-87
pubmed: 18797643
J Int AIDS Soc. 2014 Apr 28;17:18908
pubmed: 24780511
J Womens Health (Larchmt). 2008 Jan-Feb;17(1):47-55
pubmed: 18240981
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
Int J Epidemiol. 2017 Apr 1;46(2):e21
pubmed: 27208042
AIDS. 2014 Sep 10;28(14):2133-45
pubmed: 25062091
PLoS Med. 2017 Apr 11;14(4):e1002262
pubmed: 28399122
JAMA. 2006 Aug 16;296(7):782-93
pubmed: 16905784
Malawi Med J. 2010 Jun;22(2):49-56
pubmed: 21614882
PLoS Med. 2012 Feb;9(2):e1001167
pubmed: 22346735
PLoS Med. 2013;10(4):e1001418
pubmed: 23585736
Lancet HIV. 2019 Mar;6(3):e191-e200
pubmed: 30777726
J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):292-5
pubmed: 21317587
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
PLoS One. 2017 Oct 30;12(10):e0186557
pubmed: 29084275
Sci Rep. 2019 Sep 2;9(1):12621
pubmed: 31477764
South Afr J HIV Med. 2017 Jul 27;18(1):694
pubmed: 29568630
AIDS. 2017 Feb 20;31(4):545-552
pubmed: 28121668
PLoS Med. 2012;9(9):e1001304
pubmed: 22973181
Lancet HIV. 2017 Mar;4(3):e113-e121
pubmed: 27956187

Auteurs

Meg Osler (M)

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Morna Cornell (M)

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Nathan Ford (N)

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
HIV/AIDS Department and Global Hepatitis Programme, World Health Organization, Geneva, Switzerland.

Katherine Hilderbrand (K)

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Médecins Sans Frontières, Southern African Medical Unit, Cape Town, South Africa.

Eric Goemaere (E)

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Médecins Sans Frontières, Southern African Medical Unit, Cape Town, South Africa.

Andrew Boulle (A)

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Department of Health, Provincial Government of the Western Cape, Cape Town, South Africa.
Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH